Skip to search formSkip to main contentSkip to account menu

Medigoxin

Known as: Medigoxin [Chemical/Ingredient], beta-Methyldigoxin, Card-20(22)-enolide, 3-((O-2,6-dideoxy-4-O-methyl-beta-D-ribo-hexopyranosyl-(1-4)-O-2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1-4)-2,6-dideoxy-beta-D-ribo-hexopyranosyl)oxy)-12,14-dihydroxy-, (3beta,5beta,12beta)- 
A semisynthetic digitalis glycoside with the general properties of DIGOXIN but more rapid onset of action. Its cardiotonic action is prolonged by its… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
OBJECTIVE To report a significant increase in the serum levels of digoxin associated with the use of clarithromycin in six… 
1989
1989
Selected Digitalis lanata cell lines cultivated in 1‐L shake flasks or 20‐L airlift bioreactors converted β‐methyldigitoxin into… 
1983
1983
Digitalis-induced ventricular tachyarrhythmias (VTAs) are believed to be due to oscillatory afterpotentials (OAPs) generated by… 
1981
1981
In the isolated rat heart, anoxia or ischemia do not induce important ventricular tachyarrhythmias (VTAs). During the 1st min of… 
1981
1981
SummaryThe pharmacokinetics of digoxin and metildigoxin were investigated in geriatric patients on maintenance treatment. Minimum… 
1978
1978
1 The properties of a recently introduced digitalis glycoside, 4-beta-methyl digoxin (medigoxin) were compared to those of a… 
Review
1977
Review
1977
The pharmacokinetics of orally administered aqueous 3H-beta-methyldigoxin solutions were studied at two dose levels, 0.3 and 0.6… 
1977
1977
Significant decreases in left ventricular ejection time and heart rate were observed after the oral and intravenous…